☰

Georgios Karagiannis, Ph.D. - Publications

Affiliations: 
2014 Laboratory Medicine and Pathobiology University of Toronto, Toronto, ON, Canada 
Area:
Medicine and Surgery, Pathology, General Biology
Tree Info Similar researchers PubMed Report error

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Kim G, Pastoriza JM, Condeelis JS, Sparano JA, Filippou PS, Karagiannis GS, Oktay MH. The Contribution of Race to Breast Tumor Microenvironment Composition and Disease Progression. Frontiers in Oncology. 10: 1022. PMID 32714862 DOI: 10.3389/fonc.2020.01022  0.353
2019 Filippou PS, Karagiannis GS, Constantinidou A. Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target. Oncogene. 39: 2040-2054. PMID 31801970 DOI: 10.1038/s41388-019-1124-8  0.542
2019 Afaloniati H, Karagiannis GS, Karavanis E, Psarra TA, Karampatzakis-Kouritas A, Poutahidis T, Angelopoulou K. Inflammation-induced colon cancer in uPA-deficient mice is associated with a deregulated expression of Notch signaling pathway components. Molecular and Cellular Biochemistry. 464: 181-191. PMID 31758376 DOI: 10.1007/s11010-019-03659-9  0.329
2019 Karagiannis GS, Pastoriza JM, Borriello L, Jafari R, Coste A, Condeelis JS, Oktay MH, Entenberg D. Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis. Journal of Visualized Experiments : Jove. PMID 31305525 DOI: 10.3791/59633  0.537
2017 Karagiannis GS, Condeelis JS, Oktay MH. Chemotherapy-induced metastasis in breast cancer. Oncotarget. 8: 110733-110734. PMID 29340008 DOI: 10.18632/oncotarget.22717  0.329
2017 Forse CL, Rahimi M, Diamandis EP, Assarzadegan N, Dawson H, Grin A, Kennedy E, O'Connor B, Messenger DE, Riddell RH, Kirsch R, Karagiannis GS. HtrA3 stromal expression is correlated with tumor budding in stage II colorectal cancer. Experimental and Molecular Pathology. PMID 28716573 DOI: 10.1016/J.Yexmp.2017.07.002  0.409
2017 Karagiannis GS, Pastoriza JM, Wang Y, Harney AS, Entenberg D, Pignatelli J, Sharma VP, Xue EA, Cheng E, D'Alfonso TM, Jones JG, Anampa J, Rohan TE, Sparano JA, Condeelis JS, et al. Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism. Science Translational Medicine. 9. PMID 28679654 DOI: 10.1126/Scitranslmed.Aan0026  0.414
2016 Filippou PS, Karagiannis GS, Musrap N, Diamandis EP. Kallikrein-related peptidases (KLKs) and the hallmarks of cancer. Critical Reviews in Clinical Laboratory Sciences. 1-58. PMID 26886390 DOI: 10.3109/10408363.2016.1154643  0.645
2016 Karagiannis GS, Afaloniati H, Karamanavi E, Poutahidis T, Angelopoulou K. BMP pathway suppression is an early event in inflammation-driven colon neoplasmatogenesis of uPA-deficient mice Tumor Biology. 37: 2243-2255. DOI: 10.1007/s13277-015-3988-8  0.307
2015 Musrap N, Tuccitto A, Karagiannis GS, Saraon P, Batruch I, Diamandis EP. Comparative Proteomics of Ovarian Cancer Aggregate Formation Reveals an Increased Expression of Calcium-activated Chloride Channel Regulator 1 (CLCA1). The Journal of Biological Chemistry. 290: 17218-27. PMID 26004777 DOI: 10.1074/Jbc.M115.639773  0.77
2015 Karagiannis GS, Musrap N, Saraon P, Treacy A, Schaeffer DF, Kirsch R, Riddell RH, Diamandis EP. Bone morphogenetic protein antagonist gremlin-1 regulates colon cancer progression. Biological Chemistry. 396: 163-83. PMID 25153376 DOI: 10.1515/Hsz-2014-0221  0.767
2015 Musrap N, Tuccitto A, Karagiannis G, Saraon P, Diamandis E. Comparative proteomics of ovarian cancer spheroid formation reveals an increased expression of calcium-activated chloride channel regulator 1 Gynecologic Oncology. 137: 116. DOI: 10.1016/J.Ygyno.2015.01.288  0.727
2014 Karagiannis GS, Treacy A, Messenger D, Grin A, Kirsch R, Riddell RH, Diamandis EP. Expression patterns of bone morphogenetic protein antagonists in colorectal cancer desmoplastic invasion fronts. Molecular Oncology. 8: 1240-52. PMID 24812030 DOI: 10.1016/J.Molonc.2014.04.004  0.58
2014 Musrap N, Karagiannis GS, Saraon P, Batruch I, Smith C, Diamandis EP. Proteomic analysis of cancer and mesothelial cells reveals an increase in Mucin 5AC during ovarian cancer and peritoneal interaction. Journal of Proteomics. 103: 204-15. PMID 24726482 DOI: 10.1016/J.Jprot.2014.03.042  0.783
2014 Karagiannis GS, Pavlou MP, Saraon P, Musrap N, Xie A, Batruch I, Prassas I, Dimitromanolakis A, Petraki C, Diamandis EP. In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers. Journal of Proteomics. 103: 121-36. PMID 24681409 DOI: 10.1016/J.Jprot.2014.03.018  0.782
2014 Karagiannis GS, Schaeffer DF, Cho CK, Musrap N, Saraon P, Batruch I, Grin A, Mitrovic B, Kirsch R, Riddell RH, Diamandis EP. Collective migration of cancer-associated fibroblasts is enhanced by overexpression of tight junction-associated proteins claudin-11 and occludin. Molecular Oncology. 8: 178-95. PMID 24268521 DOI: 10.1016/J.Molonc.2013.10.008  0.77
2014 Karagiannis GS, Saraon P, Jarvi KA, Diamandis EP. Proteomic signatures of angiogenesis in androgen-independent prostate cancer. The Prostate. 74: 260-72. PMID 24166580 DOI: 10.1002/Pros.22747  0.742
2013 Karagiannis GS, Berk A, Dimitromanolakis A, Diamandis EP. Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1. Molecular Oncology. 7: 826-39. PMID 23659962 DOI: 10.1016/J.Molonc.2013.04.002  0.674
2013 Saraon P, Cretu D, Musrap N, Karagiannis GS, Batruch I, Drabovich AP, van der Kwast T, Mizokami A, Morrissey C, Jarvi K, Diamandis EP. Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression. Molecular & Cellular Proteomics : McP. 12: 1589-601. PMID 23443136 DOI: 10.1074/Mcp.M112.023887  0.772
2013 Cho CK, Drabovich AP, Karagiannis GS, Martínez-Morillo E, Dason S, Dimitromanolakis A, Diamandis EP. Quantitative proteomic analysis of amniocytes reveals potentially dysregulated molecular networks in Down syndrome. Clinical Proteomics. 10: 2. PMID 23394617 DOI: 10.1186/1559-0275-10-2  0.314
2012 Karagiannis GS, Poutahidis T, Erdman SE, Kirsch R, Riddell RH, Diamandis EP. Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue. Molecular Cancer Research : McR. 10: 1403-18. PMID 23024188 DOI: 10.1158/1541-7786.Mcr-12-0307  0.607
2012 Saraon P, Musrap N, Cretu D, Karagiannis GS, Batruch I, Smith C, Drabovich AP, Trudel D, van der Kwast T, Morrissey C, Jarvi KA, Diamandis EP. Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer. The Journal of Biological Chemistry. 287: 34019-31. PMID 22908226 DOI: 10.1074/Jbc.M112.384438  0.749
2012 Karagiannis GS, Petraki C, Prassas I, Saraon P, Musrap N, Dimitromanolakis A, Diamandis EP. Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis. Oncotarget. 3: 267-85. PMID 22408128 DOI: 10.18632/Oncotarget.451  0.793
2011 Prassas I, Karagiannis GS, Batruch I, Dimitromanolakis A, Datti A, Diamandis EP. Digitoxin-induced cytotoxicity in cancer cells is mediated through distinct kinase and interferon signaling networks. Molecular Cancer Therapeutics. 10: 2083-93. PMID 21859838 DOI: 10.1158/1535-7163.Mct-11-0421  0.69
2010 Karagiannis GS, Pavlou MP, Diamandis EP. Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology. Molecular Oncology. 4: 496-510. PMID 20934395 DOI: 10.1016/J.Molonc.2010.09.001  0.628
2010 Angelopoulou K, Karagiannis GS. Structural characterization and expression of five novel canine kallikrein-related peptidases in mammary cancer Mammalian Genome. 21: 516-524. PMID 20853168 DOI: 10.1007/s00335-010-9282-6  0.391
2009 Angelopoulou K, Karagiannis GS. The canine kallikrein-related peptidases 9 and 10: Structural characterization and expression in mammary cancer Mammalian Genome. 20: 758-767. PMID 19953256 DOI: 10.1007/s00335-009-9237-y  0.325
Show low-probability matches.